Paul A. Grayburn
Advanced in Cardiomyopathy

Dr. Paul A. Grayburn

Cardiology
621 N Hall St, Suite H030, 
Dallas, TX 
Clinical Trials:Currently Recruiting for 3 Trials
Accepting New Patients
Advanced in Cardiomyopathy
621 N Hall St, Suite H030, 
Dallas, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Paul Grayburn is a Cardiologist in Dallas, Texas. Dr. Grayburn is rated as an Advanced provider by MediFind in the treatment of Cardiomyopathy. His top areas of expertise are Mitral Valve Regurgitation, Tricuspid Regurgitation, Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement. Dr. Grayburn is currently accepting new patients.

His clinical research consists of co-authoring 252 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 13 articles in the study of Cardiomyopathy.

Specialties
Cardiology
Licenses
Internal Medicine in TX
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Friday Health

Accepted plan types not found. Please verify directly with the provider.

Scott and White Health
  • HMO
  • POS

Locations

621 N Hall St, Suite H030, Dallas, TX 75226

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Tricuspid Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System and Optimal Medical Therapy (OMT) Compared to OMT Alone in Patients With Tricuspid Regurgitation
A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Tricuspid Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System and Optimal Medical Therapy (OMT) Compared to OMT Alone in Patients With Tricuspid Regurgitation
Enrollment Status: Recruiting
Publish Date: September 22, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Enrollment Status: Recruiting
Publish Date: May 21, 2025
Intervention Type: Device
Study Phase: Not Applicable
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Enrollment Status: Recruiting
Publish Date: January 31, 2025
Intervention Type: Device
Study Phase: Not Applicable
Clinical Study of Edwards Cardioband FIT Valve Repair System
Clinical Study of Edwards Cardioband FIT Valve Repair System
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Device
Study Phase: Not Applicable
Edwards PASCAL TrAnScatheter Valve RePair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study
Edwards PASCAL TrAnScatheter Valve RePair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study
Enrollment Status: Completed
Publish Date: September 29, 2025
Intervention Type: Device
Study Phase: Not Applicable
Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device
Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device
Enrollment Status: Active_not_recruiting
Publish Date: August 15, 2025
Intervention Type: Device
Study Phase: Not Applicable
Expanded Clinical Study of the Tendyne Mitral Valve System
Expanded Clinical Study of the Tendyne Mitral Valve System
Enrollment Status: Completed
Publish Date: July 17, 2025
Intervention Type: Device
Study Phase: Not Applicable
Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)
Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)
Enrollment Status: Active_not_recruiting
Publish Date: November 27, 2024
Intervention Type: Device
Study Phase: Not Applicable
Annular ReduCtion for Transcatheter Treatment of Insufficient Mitral ValvE (ACTIVE): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System and GDMT vs GDMT Alone in Patients With FMR and Heart Failure
Annular ReduCtion for Transcatheter Treatment of Insufficient Mitral ValvE (ACTIVE): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System and GDMT vs GDMT Alone in Patients With FMR and Heart Failure
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Device
Study Phase: Not Applicable
A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects (COAPT Recruitment Closed). COAPT CAS (Recruitment Closed)
A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects (COAPT Recruitment Closed). COAPT CAS (Recruitment Closed)
Enrollment Status: Active_not_recruiting
Publish Date: November 27, 2023
Intervention Type: Device
Study Phase: Not Applicable
View 7 Less Clinical Trials

252 Total Publications

Transcatheter Aortic Valve Replacement With Balloon- Versus Self-Expandable Bioprostheses for the Treatment of Bicuspid Aortic Valve Stenosis.
Transcatheter Aortic Valve Replacement With Balloon- Versus Self-Expandable Bioprostheses for the Treatment of Bicuspid Aortic Valve Stenosis.
Journal: Circulation
Published: August 18, 2025
Similar Doctors
Elite in Cardiomyopathy
Dr. Mark S. Link
Cardiac Electrophysiology | Cardiology
Elite in Cardiomyopathy
Dr. Mark S. Link
Cardiac Electrophysiology | Cardiology

University Of Texas Southwestern Medical Center At Dallas

5939 Harry Hines Blvd, 
Dallas, TX 
 (4.2 miles away)
214-645-5505
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mark Link is a Cardiac Electrophysiologist and a Cardiologist in Dallas, Texas. Dr. Link is rated as an Elite provider by MediFind in the treatment of Cardiomyopathy. His top areas of expertise are Myocardial Contusion, Hypertrophic Cardiomyopathy (HCM), Ventricular Fibrillation, Cardiac Ablation, and Pacemaker Implantation.

Justin L. Grodin
Distinguished in Cardiomyopathy
Dr. Justin L. Grodin
Cardiology
Distinguished in Cardiomyopathy
Dr. Justin L. Grodin
Cardiology

University Of Texas Southwestern Medical Center At Dallas

1301 Pennsylvania Ave, 
Fort Worth, TX 
 (32.6 miles away)
817-882-3770
Experience:
16+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Justin Grodin is a Cardiologist in Fort Worth, Texas. Dr. Grodin has been practicing medicine for over 16 years and is rated as an Elite provider by MediFind in the treatment of Cardiomyopathy. His top areas of expertise are Heart Failure, Cardiac Amyloidosis, Transthyretin Amyloidosis, Heart Transplant, and Tissue Biopsy.

Vlad G. Zaha
Distinguished in Cardiomyopathy
Dr. Vlad G. Zaha
Cardiology
Distinguished in Cardiomyopathy
Dr. Vlad G. Zaha
Cardiology

University Of Texas Southwestern Medical Center At Dallas

600 S Main St, 
Fort Worth, TX 
 (31.9 miles away)
817-882-2400
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Vlad Zaha is a Cardiologist in Fort Worth, Texas. Dr. Zaha is rated as a Distinguished provider by MediFind in the treatment of Cardiomyopathy. His top areas of expertise are Cardiomyopathy, Myocarditis, Mitral Valve Regurgitation, and Cardiomyopathy Due to Anthracyclines.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Grayburn's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 33 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile